October 13, 2009 – ATS Medical Inc. today said it received CE mark for the ATS CryoMaze 10-S Surgical Cryoablation Probe for the treatment of cardiac arrhythmias.
October 13, 2009 – By mimicking the way embryonic stem cells develop into heart muscle in a lab, Duke University bioengineers believe they have taken an important first step toward growing a living heart patch to repair heart tissue damaged by disease.
October 13, 2009 – The Minneapolis Heart Institute at Abbott Northwestern Hospital with guest national faculty will present The Miracle on Ice: Therapeutic Hypothermia for Cardiac Arrest Patient Dec. 3-4, a conference that will draw physicians from across the country to learn how innovative rescue and cooling programs are saving lives and preserving brain function in cardiac arrest victims.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 12, 2009 – Daiichi Sankyo Inc. (DSI) last week said the U.S. Food and Drug Administration (FDA) approved the supplemental new drug application for Welchol (colesevelam HCl) for children and teens with heterozygous familial hypercholesterolemia (heFH).
October 12, 2009 – The Society of Cardiovascular Computed Tomography (SCCT) announced four new Category 1 CPT codes for cardiac computed tomography will become effective Jan. 1, 2010.
October 12, 2009 – Medtronic Inc. recent received CE mark and began its international launch of the Captivia Delivery System for the Valiant Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 11, 2009 – GE Healthcare announced the European launch of Discovery NM/CT 670, a hybrid imaging platform designed to improve workflow, dose management, and overall image quality, during the EANM'09 Annual Congress of the European Association of Nuclear Medicine, held Oct. 10-14 in Barcelona, Spain.
October 12, 2009 – Medicare regulatory changes expected to be finalized in November pose a threat to 80 million American patients suffering from heart disease, especially for the nearly one in four over the age of 65 living in rural areas, according to the medical lobby group Guarding Hearts Alliance.
October 9, 2009 – Clarian Cardiovascular has established the Midwest’s only Transradial Center of Excellence in an effort to offer patients a catheterization procedure that significantly reduces recovery time and improves patient outcomes using transradial cardiac catheterization instead of femoral access.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 9, 2009 – CardioPharma is beginning the final funding phase before submitting an FDA new drug application (NDA) for CardiaPill, the world's first patented triple-combination cardiovascular polypill.
October 9, 2009 – Cook Inc. has filed a lawsuit with the U.S. District Court, Southern District of Indiana, against Endologix Inc., claiming infringement of two critical patents for endovascular stent-grafts used for endovascular repair of aortic aneurysms (EVAR).
October 8, 2009 – The primary results from its groundbreaking PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) clinical trial were released at TCT 2009 in September, which shows promise in identifying and predicting how vulnerable plaque might progress to a cardiac event.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 8, 2009 – Boston Scientific Corp. this week announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial, which will determine the best device programming strategy to minimize unnecessary therapy in patients with an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) and have no history of cardiac arrest.
October 8, 2009 – In a recent survey of more than 2,000 U.S. physicians conducted by Epocrates Inc., cardiologists and other specialists shared their perspective on the latest patient visit trends and mobile technology use. With patient visits highly affected by the economy, and the use of technology growing among cardiologists, the company said.
October 8, 2009 – Lantheus Medical Imaging Inc. said two oral presentations featuring gadofosveset trisodium, the first and only FDA cleared blood pool contrast agent for magnetic resonance angiography (MRA), were presented at MRA-Club 09: The 21st Annual International Conference on Magnetic Resonance Angiography.